Source - SMW
Mercia Technologies (MERC) confirms a new direct investment of £650,000 into Medherant Ltd.  

Medherant is a novel transdermal patch drug delivery system company, and this investment brings another opportunity with high growth potential into Mercia's portfolio of direct investments.

Mercia's investment is part of a syndicated £1.5million fundraising round that would support taking the Company's patches through the Good Manufacturing Practice and pre-clinical work required to start clinical work and to enable the early commercialisation of its technology.




Related Charts

Mercia Technologies (MERC)

-0.75p (-1.51%)
delayed 18:15PM